DOCU:NASDAQDocuSign, Inc. Analysis
Data as of 2026-03-29 - not real-time
$45.71
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
DocuSign is currently priced at $45.71, which sits below its 20‑day (≈$47.4) and 50‑day (≈$48.6) simple moving averages, indicating a short‑term bearish bias. The stock is trading just above the technical support level of $44.17 and well under the resistance at $51.40, framing a relatively tight range. The 14‑day RSI of 43 points to a neutral‑to‑slightly‑oversold condition, while the MACD histogram has turned positive, hinting at a possible early momentum shift. Volume has been increasing, supporting the notion that buying interest is picking up despite the downtrend. However, the 30‑day realized volatility exceeds 40% and a beta of 1.19 signals that price swings may be amplified relative to the broader market. The Fear & Greed index currently reads “Greed,” suggesting market sentiment is tilted toward risk‑on behavior.
On the fundamentals side, DOCU delivered 7.8% revenue growth to $3.22 B and preserved a robust 79.6% gross margin, translating into a 9.6% net profit margin. Operating cash flow of $1.17 B and free cash flow of $1.20 B underscore strong cash generation, while the balance sheet shows net cash of roughly $680 M after accounting for debt. The forward EPS estimate of $5.05 pulls the forward P/E down to about 9×, markedly below the industry average of 32×, and the DCF‑derived fair value of $118 suggests more than 40% upside. Management has announced an expanded share‑repurchase program, which could further support price appreciation in the absence of a dividend. Analyst consensus remains “hold” with 18 contributors, but the median price target of $60 and mean target of $64.5 indicate expectations of a modest rally. Given the blend of undervaluation, solid profitability, and strategic focus on AI‑driven agreement management, the outlook improves for medium‑ and long‑term investors.
On the fundamentals side, DOCU delivered 7.8% revenue growth to $3.22 B and preserved a robust 79.6% gross margin, translating into a 9.6% net profit margin. Operating cash flow of $1.17 B and free cash flow of $1.20 B underscore strong cash generation, while the balance sheet shows net cash of roughly $680 M after accounting for debt. The forward EPS estimate of $5.05 pulls the forward P/E down to about 9×, markedly below the industry average of 32×, and the DCF‑derived fair value of $118 suggests more than 40% upside. Management has announced an expanded share‑repurchase program, which could further support price appreciation in the absence of a dividend. Analyst consensus remains “hold” with 18 contributors, but the median price target of $60 and mean target of $64.5 indicate expectations of a modest rally. Given the blend of undervaluation, solid profitability, and strategic focus on AI‑driven agreement management, the outlook improves for medium‑ and long‑term investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near technical support
- positive MACD histogram indicating early momentum
- high volatility and bearish moving‑average alignment
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair‑value upside of >40% versus current price
- forward P/E ~9× well below industry average
- strong cash generation and ongoing share‑repurchase program
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- AI‑powered Intelligent Agreement Management platform expanding TAM
- high gross margins and recurring revenue model
- net cash position and low leverage supporting sustainable growth
Key Metrics & Analysis
Financial Health
Revenue Growth7.80%
Profit Margin9.60%
P/E Ratio30.9
ROE15.77%
ROA4.53%
Debt/Equity9.65
P/B Ratio4.7
Op. Cash Flow$1.2B
Free Cash Flow$1.2B
Industry P/E32.0
Technical Analysis
TrendBearish
RSI43.0
Support$44.17
Resistance$51.40
MA 20$47.36
MA 50$48.58
MA 200$66.83
MACDBullish
VolumeIncreasing
Fear & Greed Index65.98
Valuation
Fair Value$117.89
Target Price$64.55
Upside/Downside41.22%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta1.19
Volatility42.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.